The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2367-2377

  Yu, Hong ^a   McDaid, Ronan ^b   Lee, John ^b   Possik, Patricia ^b   Li, Ling ^b   Kumar, Suresh M ^a   Elder, David E ^a   Van Belle, Patricia ^a   Gimotty, Phyllis ^a   Guerra, Matt ^a   Hammond, Rachel ^a   Nathanson, Katharine L ^a   Dalla Palma, Maria ^a   Herlyn, Meenhard ^b   Xu, Xiaowei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; SHORT HAIRPIN RNA; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CELL GROWTH; CHROMOSOME DELETION 13; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE;

EID: 67049168909     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081057     Document Type: Article

References (52)

1. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 2003, 33:19-20 (Pubitemid 36068675)
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954 (Pubitemid 34716871)
3. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD, Berghmans S, Mayhall EA, Traver D, Fletcher CD, Aster JC, Granter SR, Look AT, Lee C, Fisher DE, Zon LI: BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005, 15:249-254 (Pubitemid 40205706)
4. Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMahon M: A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 2007, 21:379-384 (Pubitemid 46310172)
5. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724 (Pubitemid 41117276)
6. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR: Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008, 132:363-374 (Pubitemid 351191995)
7. Sherr CJ: Principles of tumor suppression. Cell 2004, 116:235-246 (Pubitemid 38167315)
8. Box NF, Terzian T: The role of p53 in pigmentation, tanning and melanoma. Pigment Cell Melanoma Res 2008, 21:525-533
9. Hartmann A, Blaszyk H, Cunningham JS, McGovern RM, Schroeder JS, Helander SD, Pittelkow MR, Sommer SS, Kovach JS: Overexpression and mutations of p53 in metastatic malignant melanomas. Int J Cancer 1996, 67:313-317 (Pubitemid 26274118)
10. Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC: Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993, 54:693-699 (Pubitemid 23188204)
11. Sparrow LE, Soong R, Dawkins HJ, Iacopetta BJ, Heenan PJ: p53 gene mutation and expression in naevi and melanomas. Melanoma Res 1995, 5:93-100
12. Perlis C, Herlyn M: Recent advances in melanoma biology. Oncologist 2004, 9:182-187 (Pubitemid 38452117)
13. Bardeesy N, Bastian BC, Hezel A, Pinkel D, Depinho RA, Chin L: Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol 2001, 21:2144-2153 (Pubitemid 32479635)
14. Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C, Hao H, Penland S, Arbiser J, Scott G, Zhou T, Bar-Eli M, Bear JE, Der CJ, Kaufmann WK, Rimm DL, Sharpless NE: Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. Cancer Res 2007, 67:1502-1512 (Pubitemid 46389241)
15. Smalley KS, Contractor R, Haass NK, Kulp AN, Tilla-Gokcumen GE, Williams DS, Bregman H, Flaherty KT, Soengas MS, Meggers E, Herlyn M: An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res 2007, 67:209-217 (Pubitemid 46142777)
16. Haapajarvi T, Pitkanen K, Laiho M: Human melanoma cell line UV responses show independency of p53 function. Cell Growth Differ 1999, 10:163-171 (Pubitemid 29138523)
17. Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H: Cutaneous melanomas associated with nevi. Arch Dermatol 2003, 139:1620-1624 (Pubitemid 37523082)
18. Berking C, Takemoto R, Satyamoorthy K, Shirakawa T, Eskandarpour M, Hansson J, VanBelle PA, Elder DE, Herlyn M: Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res 2004, 64:807-811 (Pubitemid 38176875)
19. Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ: Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005, 115:3166-3176 (Pubitemid 41567581)
20. Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu X: Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res 2007, 67:3177-3184 (Pubitemid 46724855)
21. Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, Herlyn M, Xu X: Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 2006, 168:1879-1888 (Pubitemid 43825308)
22. Berking C, Takemoto R, Satyamoorthy K, Elenitsas R, Herlyn M: Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 2001, 158:943-953 (Pubitemid 32221786)
23. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y: Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005, 11:7234-7242 (Pubitemid 41507680)
24. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15
25. Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, deJong PJ, Zhao S, Liebman M, Weber BL: 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004, 14:179-187
26. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, bdel-Malek ZA, Marais R, Wynford-Thomas D, Bennett DC: Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006, 95:496-505
27. Wossning T, Herzog S, Kohler F, Meixlsperger S, Kulathu Y, Mittler G, Abe A, Fuchs U, Borkhardt A, Jumaa H: Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells. J Exp Med 2006, 203:2829-2840 (Pubitemid 46026161)
28. Lee AY, Kim NH, Choi WI, Youm YH: Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 2005, 124:976-983 (Pubitemid 40629099)
29. Riley T, Sontag E, Chen P, Levine A: Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9:402-412 (Pubitemid 351574202)
30. Sax JK, El-Deiry WS: p53 downstream targets and chemosensitivity. Cell Death Differ 2003, 10:413-417 (Pubitemid 36626353)
31. Rozan LM, El-Deiry WS: p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ 2007, 14:3-9 (Pubitemid 44911889)
32. Laptenko O, Prives C: Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006, 13:951-961 (Pubitemid 43753486)
33. Cheah PL, Looi LM: p53: an overview of over two decades of study. Malays J Pathol 2001, 23:9-16
34. Yu J, Zhang L: The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005, 331:851-858 (Pubitemid 40615516)
35. Sherr CJ, McCormick F: The RB and p53 pathways in cancer. Cancer Cell 2002, 2:103-112 (Pubitemid 41039110)
36. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W: Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 2002, 12:162-169 (Pubitemid 34219488)
37. Yu T, MacPhail SH, Banath JP, Klokov D, Olive PL: Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair (Amst) 2006, 5:935-946 (Pubitemid 44160591)
38. Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, Gray JW, Naber SP, Weinberg RA: The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 2005, 37:1047-1054 (Pubitemid 41486656)
39. Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA: Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 2005, 37:745-749 (Pubitemid 41754892)
40. Johansen J, Rosenblad C, Andsberg K, Moller A, Lundberg C, Bjorlund A, Johansen TE: Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther 2002, 9:1291-1301
41. Gilyarov AV: Nestin in central nervous system cells. Neurosci Behav Physiol 2008, 38:165-169
42. Lin AW, Barradas M, Stone JC, van AL, Serrano M, Lowe SW: Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998, 12:3008-3019 (Pubitemid 28469303)
43. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602 (Pubitemid 27152402)
44. Zhu J, Woods D, McMahon M, Bishop JM: Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998, 12:2997-3007 (Pubitemid 28469302)
45. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001, 409:207-211 (Pubitemid 32144287)
46. Hussein MR, Haemel AK, Wood GS: Apoptosis and melanoma: molecular mechanisms. J Pathol 2003, 199:275-288 (Pubitemid 36266850)
47. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F: Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444: 638-642 (Pubitemid 44864443)
48. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG: Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637 (Pubitemid 44864442)
49. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G: The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007, 21:43-48 (Pubitemid 46089705)
50. Mitsutake N, Knauf JA, Mitsutake S, Mesa C Jr, Zhang L, Fagin JA: Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 2005, 65:2465-2473 (Pubitemid 40490159)
51. Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L: Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene 2003, 22:5055-5059 (Pubitemid 37026403)
52. Yang G, Rajadurai A, Tsao H: Recurrent patterns of dual RB and p53 pathway inactivation in melanoma. J Invest Dermatol 2005, 125:1242-1251